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Cholesterol loading suppresses 
the atheroinflammatory 
gene polarization of human 
macrophages induced by colony 
stimulating factors
Jani Lappalainen1, Nicolas Yeung1, Su D. Nguyen1, Matti Jauhiainen2, Petri T. Kovanen1* & 
Miriam Lee‑Rueckert1
In atherosclerotic lesions, blood‑derived monocytes differentiate into distinct macrophage 
subpopulations, and further into cholesterol‑filled foam cells under a complex milieu of cytokines, 
which also contains macrophage‑colony stimulating factor (M‑CSF) and granulocyte–macrophage‑
colony stimulating factor (GM‑CSF). Here we generated human macrophages in the presence of either 
M‑CSF or GM‑CSF to obtain M‑MØ and GM‑MØ, respectively. The macrophages were converted into 
cholesterol‑loaded foam cells by incubating them with acetyl‑LDL, and their atheroinflammatory 
gene expression profiles were then assessed. Compared with GM‑MØ, the M‑MØ expressed higher 
levels of CD36, SRA1, and ACAT1, and also exhibited a greater ability to take up acetyl‑LDL, esterify 
cholesterol, and become converted to foam cells. M‑MØ foam cells expressed higher levels of ABCA1 
and ABCG1, and, correspondingly, exhibited higher rates of cholesterol efflux to apoA‑I and  HDL2. 
Cholesterol loading of M‑MØ strongly suppressed the high baseline expression of CCL2, whereas 
in GM‑MØ the low baseline expression CCL2 remained unchanged during cholesterol loading. The 
expression of TNFA, IL1B, and CXCL8 were reduced in LPS‑activated macrophage foam cells of 
either subtype. In summary, cholesterol loading converged the CSF‑dependent expression of key 
genes related to intracellular cholesterol balance and inflammation. These findings suggest that 
transformation of CSF‑polarized macrophages into foam cells may reduce their atheroinflammatory 
potential in atherogenesis.
Macrophages substantially impact the development and progression of atherosclerosis through their diverse roles 
in cholesterol metabolism and by regulating innate immune  responses1–3. Formation of an atherosclerotic lesion 
is characterized by the accumulation of LDL-derived as well as lipoprotein remnant-derived cholesterol in the 
lesional macrophages leading to foam cell formation and chronic inflammatory responses in the arterial  intima4–6.
Stimulation of cholesterol efflux from macrophage foam cells by HDL can significantly compensate for the 
influx of cholesterol, and such cholesterol efflux capacity of HDL is considered the main cardioprotective func-
tion of this class of  lipoproteins7. Cholesterol efflux from macrophage foam cells occurs via several pathways, 
quantitatively the most effective mechanism involves the ATP-binding cassette (ABC) transporters A1 and G1, 
which upon interaction with lipid-poor and mature HDL, respectively, trigger a cascade of events associated 
with the release of cholesterol and phospholipids from the foam  cells8,9. By disrupting the specialized choles-
terol and sphingomyelin-rich lipid rafts, which serve as platforms in the macrophage plasma membrane for 
inflammatory signaling pathways, cholesterol efflux is associated with anti-inflammatory effects and proper 
immune  responses10. Such link between cholesterol efflux and inflammation is supported by data showing that 
cholesterol accumulation in the plasma membrane of  Abca1−/−,  Abcg1−/−, and  Abca1−/−Abcg1−/− macrophages 
increases signaling of Toll-like receptors (TLR), thereby enhancing the inflammatory response to LPS and other 
TLR  ligands11–13. Furthermore, it was reported that ABCA1 can also function as an anti-inflammatory signaling 
receptor in macrophages through activation of STAT3, an effect independent of cholesterol efflux  induction14.
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Macrophage colony-stimulating factor (M-CSF) and granulocyte–macrophage colony-stimulating factor 
(GM-CSF) are soluble glycoproteins widely expressed in the arterial  intima15. They regulate the differentiation 
of mononuclear phagocytic cells into mature macrophages and also affect their functional  properties16. During 
atherogenesis, exposure to CSFs and other polarizing factors modulates the generation of macrophage popula-
tions with divergent genomic signatures and functional properties that may impact their atherogenic  roles15. 
Thus, upon exposure of monocytes to M-CSF or GM-CSF, 2 major macrophage subtypes are generated which 
exhibit distinct cell morphologies, antigen expression, and functional responses, although also several overlap-
ping features  exist17–19.
Even though various macrophage subtypes exhibit functional diversity in vascular biology, they have been 
only partially  mapped20. Importantly, the pre-foam-cell macrophages resemble strong phenotypic plasticity 
when activated, with a spectrum ranging from pro-inflammatory to wound-healing and regression-driving 
 phenotypes1. As such, any dichotomous classification of macrophages only represents the opposite ends of a 
wide spectrum of macrophage phenotypes, yet it provides a useful concept to discuss the role of macrophages 
in inflammation and its resolution in atherosclerotic  plaques21,22. Moreover, given the complexity of the tissue 
microenvironment and the ability of macrophages to undergo metabolic adaptations to sustain their activities, a 
static vision of macrophage polarization generated in vitro may not fully reflect the dynamic and tissue-specific 
macrophage polarization in vivo23. Interestingly, however, a macrophage subpopulation predominating in human 
atherosclerotic lesions has been shown to resemble macrophages generated in vitro in the presence of M-CSF 
and IL-1019.
The transformation of macrophages into foam cells plays a central role in atherogenesis. This process also 
strongly affects their gene expression profile. Therefore, investigation of the mechanism by which human mono-
cyte-derived macrophages generated via different CSF treatments in vitro react to cholesterol loading becomes of 
particular interest to understand better the potential mechanisms operating in vivo. In mice, genes linked to lipid 
metabolism, complement activation, or lysosomal function are differentially overexpressed in cholesterol-loaded 
macrophages indicating that the cholesterol cargo is capable of regulating functional macrophage properties 
implicated in  atherogenesis24. However, functional correlates of mouse and human macrophages and their rep-
resentative cell subtypes have not been fully defined, so presenting a barrier for a comprehensive understanding 
of macrophage subpopulations in human atherogenesis.
Since CSF-macrophage subpopulations have already been identified in human coronary  arteries19 and various 
subtypes are being involved in distinct roles regarding progression or regression of atherosclerotic  plaques25, it 
is pertinent to pose a question of whether the cholesterol-rich environment, such as prevailing in the athero-
sclerotic intima, can modulate the CSF-induced gene polarization of human macrophages. To address this, we 
investigated in vitro the effect of cholesterol loading on the expression of selected genes which play essential 
roles in the regulation of cholesterol balance and inflammation in human macrophage foam cells differentiated 
solely under the influence of either M-CSF or GM-CSF. Our results demonstrate that the transformation of 
human monocyte-derived macrophages into foam cells converges the gene expression profiles of the macrophage 
subtypes polarized with either CSF, thereby reducing their CSF-dependent atheroinflammatory polarization.
Results
Phenotypic macrophage markers are expressed at different levels in the presence of M‑CSF 
or GM‑CSF. To gain knowledge about the effect of CSFs on human macrophage gene expression profile, we 
analyzed the cells (i) after monocyte differentiation into macrophages with either M-CSF or GM-CSF (“M-MØ 
and GM-MØ”), (ii) after cholesterol loading of the generated macrophages with acetyl-LDL to yield “Foam cells 
M-MØ and GM-MØ”, and (iii) after cholesterol efflux of the generated foam cell macrophages with cholesterol 
acceptors to yield “Regressing foam cells M-MØ and GM-MØ” (Supplementary Fig. S1).
After 6 days of monocyte differentiation in the presence of either CSF, the cells were immunostained for the 
macrophage markers CD68 and CD14. As previously reported in human monocyte-derived  macrophages17,19,26, 
 CD14+ cells predominated in cultures incubated with M-CSF, while CD68 was uniformly expressed in either 
CSF culture, indicating a phenotypic conversion into 2 major macrophage subsets (Supplementary Fig. S2). 
Because GM-CSF-treated monocytes are widely used as a model for the development of dendritic  cells16, we 
immunophenotyped the dendritic cell markers CD11c and CCR7 in cells differentiated with GM-CSF in the 
absence or presence of IL-4, the latter capable of inducing dendritic cell formation in vitro27. In line with the 
immunostaining data, monocytes incubated with GM-CSF were differentiated into  CD68+ cells which also 
expressed the CD14 antigen (Supplementary Fig. S3, top panel left); however, when monocytes were differentiated 
with GM-CSF and IL-4, the generated cells were  CD68+/CD14− (Supplementary Fig. S3, top panel right). These 
cells also expressed the dendritic cell marker CD11c and some expressed CCR7, whereas the cells differentiated 
in the absence of IL-4 were  CD11c+/CCR7− (Supplementary Fig. S3, top panel left). Besides, overlaid histograms 
were generated to compare antigen expression intensity for CD14, CD11c, and CCR7 (Supplementary Fig. S3, 
bottom panel). These data confirm previous observations indicating that the expression patterns of cell surface 
markers in human macrophages and dendritic cells partially  overlap28. Thus, in the presence of IL-4, the GM-
CSF generated cells with characteristics of immature dendritic cells, as shown by negative staining for CD14, 
and only a few mature dendritic cells expressing the CCR7 antigen. Overall, the data indicated that the present 
experimental culture setting generated 2 subtypes of cells identified as macrophages rather than dendritic cells. 
Therefore, human monocytes differentiated either with M-CSF or GM-CSF were designated as the macrophage 
subtypes M-MØ and GM-MØ, respectively.
Gene expression profile characterizes M‑MØ as more proatherogenic and pro‑inflammatory 
than GM‑ MØ. To characterize further the phenotypes of macrophages polarized in the sole presence of 
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either CSF, expression of relevant genes related to cholesterol uptake, cholesterol efflux, and inflammation was 
examined. Accordingly, we evaluated the mRNA expression of 8 key molecules controlling lipid uptake (CD36, 
SRA1), HDL-facilitated cholesterol efflux (ABCA1, ABCG1, apoE) and those affecting intracellular cholesterol 
traffic pathways (ACAT1, nCEH), as well as CCL2, a known amplifier of the inflammatory response. The basal 
gene profiles of the freshly differentiated cells indicated stronger expression in the M-MØ for the majority (5 out 
of 8) of the studied genes (Fig. 1, see “Macrophages” columns) reflecting greater plasticity of macrophages which 
had been polarized in M-CSF medium. In these cells, higher expression of genes encoding scavenger recep-
tors for modified-LDL uptake (CD36 and SRA1) and the cholesterol esterification enzyme (ACAT1), and lower 
expression of the gene related to cholesteryl ester hydrolysis (nCEH) suggested that the M-MØ macrophage 
subtype was particularly prone to foam cell formation. Analysis of the expression of genes related to cholesterol 
efflux indicated that levels of ABCA1 and APOE (encoding apolipoprotein E, which induces ABCA1-mediated 
cholesterol  efflux29) were higher while that of ABCG1 was markedly lower (~ 20-fold) in M-MØ, as compared to 
GM-MØ. In agreement with a recent  report30, M-CSF polarization also induced roughly fivefold higher expres-
sion of CCL2, a macrophage inflammatory marker critical for monocyte recruitment. Such contrasting CSF-
dependent regulatory effects on ABCG1 and CCL2 have also been reported in monocytes differentiated with 
M-CSF or GM-CSF in the presence of IL-10 and serum, i.e. in a medium containing a myriad of macrophage-
Figure 1.  Expression of genes responsible for cholesterol accumulation and inflammation in M-CSF or 
GM-CSF-polarized macrophages before and after their conversion into foam cells in the absence of CSF. Gene 
expression levels were determined by quantitative RT-PCR in M-MØ and GM-MØ before (Macrophages) 
and after (Foam cells) cholesterol loading with acetyl-LDL (25 µg/mL). Data are presented as means ± SEM of 
10 individual blood donors and triplicate incubations for each studied gene. *p < 0.05 and **p < 0.01 denote 
statistically significant difference between the expression levels in M-MØ and GM-MØ, both before and after 
cholesterol loading, by Wilcoxon Signed-Rank test for paired samples.
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polarizing  factors19. Considering the reported anti-inflammatory role of ABCG1 in  macrophages31 and the well-
known effect of CCL2 as a chemoattractant for amplifying inflammatory  response32, monocytes differentiated 
under the sole influence of M-CSF had gained pro-inflammatory traits. Of note, M-CSF or GM-CSF was the 
only essential growth factor present in the minimal serum-free culture medium employed and, evidently, suf-
ficient for the observed cellular effects.
Cholesterol loading converges gene expression in CSF‑polarized macrophages. Next, we inves-
tigated how the divergent gene profile of the CSF-differentiated macrophage subtypes is modified upon mac-
rophage conversion into foam cells for the fact that the macrophage subtypes appeared to have distinct foam cell-
forming and pro-inflammatory potentials. For this purpose, the macrophages were incubated with acetyl-LDL in 
the absence of CSFs to avoid any reported effects of respective CSF on the expression of scavenger  receptors33,34, 
and the gene profiles of the foam cells were compared with those assessed in the basal macrophages.
As shown in Fig. 1 (see “Foam cells” columns), cholesterol loading did not change the mRNA expression levels 
of CD36, SRA1, or ACAT1 in either macrophage subtype, while induction of nCEH in both subtypes of foam cells 
reduced the difference observed in nCEH expression between M-MØ and GM-MØ at the basal stage (top panels, 
compare “Macrophages” vs “Foam cells” columns). Interestingly, cholesterol loading increased the expression of 
3 genes related to cholesterol efflux (ABCA1, ABCG1, APOE) and reduced the expression of CCL2, a gene whose 
high expression level signifies  inflammation32. Accordingly, all observed changes in the gene expression levels 
dampened the divergences between the basal M-MØ and GM-MØ (bottom panels, compare “Macrophages” vs 
“Foam cells” columns), so resulting in a more convergent gene profile in the 2 foam cell subtypes. Moreover, 
the pro-inflammatory features observed in M-MØ at the basal stage were strongly suppressed in response to 
cholesterol loading as indicated by the 60-fold upregulation of ABCG1 and twofold downregulation of CCL2. In 
contrast, immunophenotyping of surface antigens demonstrated that the respective CSF-specific markers  CD68+/
CD14+/CD11c+ of the 2 macrophage subtypes remained unaltered after cholesterol loading strongly indicating 
that the foam cells maintained their respective CSF phenotypic signature (Supplementary Fig. S4).
In a separate control experiment, we examined whether the observed changes induced by cholesterol loading 
in M-MØ and GM-MØ phenotypes also occurred when either CSF was included in the culture media during 
incubation in the presence of acetyl-LDL. As shown in Fig. 2, changes induced in the gene expression of the foam 
cell subtypes were similar to those observed in cells incubated in the absence of CSF (see Fig. 1). Importantly, 
the strong shifts in the expression of ABCG1 (~ 30-fold increase) and CCL2 (~ twofold decrease) were observed 
in M-MØ foam cells, again, in the presence of CSF. Overall, these data provide additional support to the notion 
that, while both CSFs differentially target key regulatory genes involved in cholesterol efflux and inflammation 
during macrophage polarization, the intracellular cholesterol accumulation, but not the type of CSF, modulates 
the expression of these genes during the conversion of the CSF macrophage subtypes into foam cells. Thus, we 
considered justified that after the CSF-driven period of macrophage differentiation, subsequent cell incubations 
were performed in media devoid of CSF.
We also examined the expression of genes related to cholesterol balance and inflammation in cholesterol-
loaded M-MØ and GM-MØ after the foam cells were incubated in the presence of human normolipidemic 
plasma (“Regressing foam cells”). This analysis was performed using CSF-polarized macrophages derived from 
monocytes isolated from the blood of 7 healthy donors (Fig. 3). Neither cholesterol loading nor cholesterol 
efflux modified CD36 or SRA1 expression in either macrophage subtype and, accordingly, higher levels of these 
scavenger receptors remained in M-MØ after each incubation step (Fig. 3A). In contrast, consistent with the 
sterol-sensitive regulation of ABC  transporters35, cholesterol loading increased and cholesterol efflux decreased 
ABCA1 and ABCG1 expression in either MØ subtype (Fig. 3B). Although the CSF-specific gene responses were 
highly variable between donors, as a rule, macrophages expressing more ABCA1 also expressed more ABCG1, 
irrespective of the CSF subtype. Thus, in Donor #5 upregulation of ABC genes in response to cholesterol loading 
was much lower when macrophages were polarized with M-CSF than with GM-CSF, whereas in Donor #2, #4, 
and #6 similar responses were observed to either CSF (low in Donor #2; high in Donors #4 and #6). Notably, 
concerning the inflammatory marker CCL2, its expression in M-MØ foam cells was significantly decreased 
by cholesterol loading, and cholesterol removal easily reversed this effect (Fig. 3B). In contrast, the weak basal 
expression of CCL2 in GM-MØ cells remained unaffected by cholesterol loading and unloading. These data 
indicated that CCL2 expression was particularly responsive to cellular cholesterol homeostasis in macrophages 
polarized with M-CSF. Since circulating monocytes consist of a heterogeneous pool of at least 3 distinct  subsets36, 
the observed donor-dependent variation in the expression of ABC genes may be attributed to the phenotypic 
state of the monocytes prior polarization reflecting a variable abundance of CSF receptors.
The gene expression response to LPS of inflammatory cytokines is reduced in choles‑
terol‑loaded macrophages. LPS-induced activation of CSF-polarized murine and human macrophages 
has been reported to result in divergent cytokine secretion  profiles37,38. Thus, we investigated further whether 
the regulatory effect of foam cell formation on CCL2 expression observed in M-CSF-polarized macrophages also 
applies to other selected relevant inflammatory cytokines. For this aim, mRNA expression of IL1B, TNFA, and 
CXCL8, which are significantly expressed by LPS-activated human  macrophages39, was assessed in non-loaded 
(“Macrophages”) and cholesterol-loaded (“Foam Cells”) of either CSF subtype, which had been incubated for 3 h 
in the absence or presence of LPS (Fig. 4).
In the absence of LPS (non-activated cells), no significant difference in the basal expression of the selected 
cytokines was found between the 2 non-loaded macrophage subtypes (Fig. 4, top panel) and, moreover, cho-
lesterol loading induced similar expression trends in either foam cell subtype by slightly increasing (IL1B) or 
decreasing (TNFA and CXCL8) mRNA expression. Thus, overall, foam cell formation appeared to suppress the 
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expression of inflammatory cytokines in both CSF macrophage subtypes. We, next, examined cytokine expres-
sion in the non-loaded and cholesterol-loaded M-MØ and GM-MØ after incubation in the presence of LPS 
(activated cells), and data were expressed as fold-changes relative to those found in the respective type of non-
activated cells (Fig. 4, bottom panel). We found that LPS induced the expression of IL1B, TNFA, and CXCL8 
in each CSF macrophage subtype irrespective of their cholesterol cargo, i.e. both in non-loaded and foam cells. 
Yet, foam cell conversion tended, again, to ameliorate cytokine expression in the LPS-activated macrophages 
(compare “Macrophages” and “Foam Cells” groups). These results indicate that cholesterol loading exerted a 
regulatory effect on macrophage inflammatory profile with a tendency to suppress the expression of, at least, the 
3 selected cytokines. Given the well-known roles of these cytokines in acute inflammation, such an unpredicted 
result indicates that the worsening of inflammatory markers manifested in LPS-treated human macrophages 
was attenuated in the foam cell phenotype. Of interest, the cytokine response to LPS in the M-MØ subtype was 
markedly stronger and therefore, the expression levels of IL1B, TNFA, and CXCL8 remained significantly higher 
in M-MØ foam cells despite their attenuation by cholesterol-loading (see bottom panel).
Transcription factors show differential gene expression in cholesterol‑loaded M‑MØ and 
GM‑MØ. LXRs are known as cholesterol sensors that reciprocally regulate genes involved in cholesterol 
efflux and  inflammation40. Importantly, LXRα and PPARα increase both ABCA1 and ABCG1 expression in 
 macrophages35, while a recent report indicated that PPARγ induces ABCG1 but decreases ABCA1  expression41. 
To learn about mechanisms by which cholesterol cargo regulates the expression of ABC transporters in the 2 
macrophage subtypes, we analyzed the cholesterol contents and mRNA levels of ABCA1 and ABCG1 in M-MØ 
and GM-MØ incubated with acetyl-LDL (ac-LDL) or oxidized-LDL (ox-LDL), both ligands of scavenger recep-
tors, or native LDL, which can also induce macrophage cholesterol accumulation by fluid  pinocytosis42. Adding 
equal concentrations of LDL (25 µg/mL) to the culture media, macrophage cholesterol contents were induced 
efficiently by ac-LDL, and modestly by ox-LDL and native LDL in either macrophage subtype (Fig. 5A). As pre-
dicted by the higher levels of scavenger receptor expression in M-MØ (see Fig. 1), exposure to ac-LDL induced 
Figure 2.  Expression of genes responsible for cholesterol accumulation and inflammation in M-CSF or 
GM-CSF-polarized macrophages before and after their conversion into foam cells in the presence of CSF. Gene 
expression levels were determined by quantitative RT-PCR in M-MØ and GM-MØ before (Macrophages) and 
after (Foam cells) cholesterol loading with acetyl-LDL (25 µg/mL) in the presence of the respective CSF. Data 
are presented as means ± SEM of 5 individual blood donors and triplicate incubations for each studied gene. 
*p < 0.05 and **p < 0.01 denote statistically significant differences between the expression levels in M-MØ and 
GM-MØ, both before and after cholesterol loading, by Wilcoxon Signed-Rank test for paired samples.
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cholesterol accumulation by about twofold in the M-MØ compared to GM-MØ. Overall, irrespective of the 
LDL type used for cholesterol-loading, macrophages overexpressed both ABC mRNAs in a similar manner, 
and quantitatively proportional to the degree of loading. Yet, of the 2 ABC transporters, ABCG1 expression was 
stronger in both CSF foam cell subtypes. Accordingly, a robust loading of M-MØ with ac-LDL increased the cel-
lular cholesterol content about fivefold, which was related to about fivefold increase in ABCA1 expression and a 
Figure 3.  Gene expression of scavenger receptors, ABC transporters, and CCL2 in M-MØ and GM-MØ after 
cholesterol influx and efflux. M-MØ and GM-MØ were analyzed for expression of (A) CD36 and SRA1, and (B) 
ABCA1, ABCG1, and CCL2 before (Macrophages) and after (Foam cells) incubation with acetyl-LDL, and after 
cholesterol efflux to an unfractionated pool of human plasma (2.5%) (Regressing foam cells), as described in 
Supplementary Fig. S1. Data from 7 individual blood donors are presented as means of triplicate incubations for 
the mRNA values at each data point. *p < 0.05 by Wilcoxon Signed-Rank test for paired samples.
Figure 4.  Gene expression of inflammatory cytokines in cholesterol-loaded M-MØ and GM-MØ after 
LPS activation. The mRNA expression of 3 key cytokines with proinflammatory properties (IL-1β, TNF-α, 
and CXCL8) by activated human macrophages was evaluated after incubation of non-loaded macrophages 
(“Macrophages”) and cholesterol-loaded macrophages (“Foam Cells”) of each CSF subtype for 3 h with LPS. 
The cytokine expression in LPS-activated macrophages (bottom panels) was expressed as fold-changes relative 
to their levels in the respective non-activated MØ subtypes (top panels). For each condition, data are presented 
as means ± SEM of 3 individual blood donors, and triplicate incubations for each condition. *p < 0.05 denotes 
statistically significant differences determined by Wilcoxon Signed-Rank test for paired samples.
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40-fold increase in ABCG1 expression (Fig. 5B,C). Analysis of the expression of transcription factors indicated 
that M-MØ expressed significantly higher basal levels of LXRA and PPARG than the GM-MØ subtype and in 
response to ac-LDL treatment the expression of these transcription factors significantly increased only in M-MØ 
foam cells (Fig. 5D,E). In contrast, the expression of PPARG was similar between the 2 non-loaded macrophage 
subtypes and was increased by cholesterol loading only in GM-MØ (Fig. 5F).
M‑MØ foam cells are functionally competent in cholesterol efflux. Next, we determined the effi-
ciency of the 2 macrophage foam cell subtypes to esterify internalized cholesterol and release their cholesterol 
cargo in response to extracellular cholesterol acceptors (Fig. 6). Since cholesterol esterification via ACAT1 is the 
main mechanism available to attenuate cytotoxic free cholesterol accumulation and deposit as cholesterol fatty 
acyl esters in lipid droplets, we evaluated ACAT1 activity in both CSF macrophage subtypes. For this, the rates 
of  [3H]oleate incorporation into cholesteryl esters were measured in M-MØ and GM-MØ in the absence or 
Figure 5.  Effect of cholesterol loading on the gene expression of ABC transporters and related transcription 
factors in M-MØ and GM-MØ foam cells. M-MØ and GM-MØ were cholesterol-loaded for 24 h with 25 µg/
mL of acetyl-LDL (ac-LDL), oxidized-LDL (ox-LDL), or native LDL. (A) Cholesterol was quantified by HPTLC, 
and expression of (B) ABCA1 and (C) ABCG1 was determined by quantitative RT-PCR. Data in panels (B) and 
(C) indicate mRNA expression levels relative to those in the non-loaded cells (Macrophages) (set at 1). Gene 
expression of (D) LXRA, (E) PPARA , and (F) PPARG was determined in acetyl-LDL generated foam cells of 
each subtype. Data in panels (D) to (F) indicate mRNA values expressed as arbitrary units. *p < 0.05, **p < 0.01, 
and ***p < 0.001 by one-way ANOVA. Data are presented as means ± SEM of 4–9 individual blood donors and 
triplicate incubations for each loading condition and gene of interest.
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presence of ac-LDL. Consistent with higher ACAT1 expression in M-MØ (see Fig. 1), these cells also displayed 
greater efficiency for cholesterol esterification, both in the non-loaded and cholesterol-loaded phenotypes, as 
Figure 6.  Cholesterol esterification activity, apoE secretion, and cholesterol efflux in M-MØ and GM-MØ 
foam cells. (A) ACAT1-mediated esterification activity was measured as the rate of  [3H]oleate incorporation 
into cholesteryl esters in M-MØ and GM-MØ which were incubated in the absence (Macrophages) or presence 
(Foam cells) of acetyl-LDL, after which the cells were incubated with  [3H]oleic acid-BSA complexes. Cellular 
lipids were extracted and  [3H]-activity was determined. (B) Cholesterol contents in the foam cells of each CSF 
subtype. (C) Cholesterol contents in M-MØ and GM-MØ before (Macrophages) and after incubation with 
acetyl-LDL (Foam cells), and after cholesterol efflux to apoA-I (10 µg/mL) and  HDL2 (25 µg/mL) (Regressing 
foam cells). (D) Macrophages were loaded with cholesterol and cholesterol efflux was induced by adding apoA-I 
or  HDL2 to the incubation medium, and the concentrations of apoE in the media were determined by ELISA. 
(E) Cholesterol efflux from  [3H]CE-labeled macrophage foam cells of either subtype was evaluated by measuring 
the macrophage-derived  [3H]-radioactivity in media when the cells were incubated with medium alone, 
apoA-I or  HDL2. Fractional efflux was calculated as [dpm medium/(dpm cells + dpm medium)] × 100. Data 
are presented as means ± SEM of 9 (A); 17 (B); 2 (C); 6 (D); and 6 (E) individual blood donors and triplicate 
incubations for each studied condition. **p < 0.01 and ***p < 0.001 by Student’s t-test for paired samples (A,B); 
*p < 0.05 by Wilcoxon Signed-Rank test for paired samples (triplicate wells per assay) (C); *p < 0.05 by Student’s 
t-test for paired samples (D); *p < 0.05 by Student’s t-test for paired samples (E).
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compared to the respective GM-MØ (Fig. 6A). The data (Fig. 6B) accord with their higher capacity for choles-
terol uptake reported  earlier34. The cholesterol content of M-MØ and GM-MØ foam cells were also quantified 
after incubation with apoA-I or  HDL2 which stimulate ABCA1- or ABCG1-dependent cholesterol efflux path-
ways,  respectively8 (see the experimental outline in Supplementary Fig. S1). As shown in Fig. 6C, macrophage 
cholesterol depletion was efficiently induced by incubating either CSF foam cell subtype with each cholesterol 
acceptor, yet the residual cellular cholesterol cargo remained higher in the regressing M-MØ foam cells.
For the fact that human macrophages do not secrete apoA-I, yet they can secrete small amounts of  apoE43 as 
an alternative ligand to stimulate ABCA1-mediated cholesterol  efflux29, we analyzed apoE contents in the cul-
ture media and determined the rates of apoE secretion from non-loaded, cholesterol-loaded, and in regressing 
macrophages of both CSF subtypes (Fig. 6D). In accordance to earlier  reports44,45, cholesterol loading increased 
apoE secretion both in M-MØ and GM-MØ whereas the non-loaded and cholesterol-loaded M-MØ secreted 
greater amounts of apoE compared to the respective GM-MØ (left panel). This reflects both stimulatory as well as 
inhibitory effects on apoE secretion reported in human macrophages exposed either to M-CSF or to GM-CSF46,47. 
Next, the culture media were replaced and the foam cells of either CSF subtype were incubated for 18 h in fresh 
medium in the absence or presence of apoA-I or  HDL2. Quantitation of secreted apoE in the culture media (right 
panel) showed low secretion from foam cell macrophages incubated in medium alone. In contrast and in line 
with previous  reports48,49, supplementing the media with apoA-I or  HDL2 significantly increased apoE secretion, 
which was more enhanced in GM-MØ. The more robust modulatory effects of cholesterol loading and cholesterol 
efflux on M-MØ indicate that the sterol-mediated regulation of apoE secretion is more tightly coordinated in the 
M-MØ rather than in GM-MØ. Finally, the cholesterol efflux capacity of  [3H]CE-labeled macrophage foam cells 
of either subtype was evaluated (Fig. 6E). Notably, the addition of either apoA-I or  HDL2 to the macrophage foam 
cell cultures significantly induced more efficient cholesterol efflux from the macrophages that had been polarized 
in M-CSF. In summary, these data indicate that greater residual cholesterol cargo found in the regressing M-MØ 
foam cells (Fig. 6C) was due to their higher cholesterol uptake and esterification properties and does not derive 
from any compromised cholesterol removal capacity via the ABCA1 or ABCG1 pathways.
GM‑MØ support greater T cell proliferation than M‑MØ in the presence of PHA. Finally, to get 
further insight into other key functional feature of the CSF-macrophage foam cells, we evaluated the effect of 
cholesterol loading on the capacity of each CSF macrophage subtype to interact with surrounding cells. Since 
both macrophages and T cells coexist in atherosclerotic lesions and play a major role in atherosclerosis progres-
sion, we cocultured GM- and M-MØ with T cells isolated from the respective donors and investigated if cho-
lesterol loading of CSF-polarized macrophages also elicited distinct macrophage immune responses affecting 
proliferation of neighboring T cells via cell–cell interactions. For this purpose, autologous T cells were co-cul-
tured with non-loaded or cholesterol-loaded macrophages of either CSF subtype in the presence of the mitogen 
phytohemagglutinin (PHA) to induce T cell proliferation. As shown in Fig. 7, in the presence, but not absence 
of PHA, co-culture with either non-loaded macrophage subtype was able to induce T cell proliferation, yet, 
the GM-MØ were more potent accessory cells compared to M-MØ. Moreover, cholesterol loading of GM-MØ, 
but not M-MØ, increased their ability to induce T cell responses in autologous cultures, so enhancing T cell 
Figure 7.  Effect of lipid-loading on the capability of M-MØ and GM-MØ to support T cell proliferation. For 
each experiment, M-MØ and GM-MØ were prepared from a buffy coat derived from a single human donor. 
The macrophages were incubated in the absence or presence of acetyl-LDL (25 µg/mL) for 24 h in serum-free 
DMEM, after which the cells were washed, autologous T cells were added and co-cultured in the presence or 
absence of 10 µg/mL phytohemagglutinin (PHA). As a control, the T cellswere cultured alone (grey bars). After 
4 days, the T cell numbers in the medium were counted. T cell proliferation was expressed as a stimulation 
index defined as a ratio obtained by dividing the number of viable T cells in the presence of macrophages by the 
number of viable T cells in the absence of macrophages. Data (means ± SEM) are derived from triplicate wells 
and correspond to 3 monocyte donors. *p < 0.05 by Wilcoxon Signed-Rank test for paired samples.
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proliferation, which has been implicated in the growth of atherosclerotic plaque in  mice50. Regarding the abil-
ity of macrophages to support T cell survival, no significant differences were observed between non-loaded or 
cholesterol-loaded M-MØ or GM-MØ (not shown).
Discussion
M-CSF is a cytokine constitutively expressed and ubiquitously produced by many cell types, while GM-CSF 
is mainly produced by activated leukocytes and synthesized in large amounts under various inflammatory 
 conditions51. Thus, differentiation of macrophages with M-CSF or GM-CSF has been described to prime the 
cells toward an anti-inflammatory or pro-inflammatory phenotype, respectively. However, several reports indi-
cate that these polarization pathways regarding inflammatory activation have not been fully reached in the 
CSF-differentiated  macrophages26,51. Moreover, lack of consensus on the differentiation protocols in vitro and 
the available nomenclature to clearly define the generated macrophage subpopulations have led to many dis-
crepancies and calls for the establishment of uniform standards in experimental  studies52. In this regard, the 
differentiation of human blood-derived monocytes into macrophages in the presence of serum typically generates 
heterogeneous macrophage  populations53 since serum preparations contain variable concentrations of cytokines 
and growth factors, among them the M-CSF and the GM-CSF, and also an array of potential activators of signal-
ing pathways in macrophages, which affect both their phenotype and function. The use of a culture medium of 
complex composition can lead to confounding and as well as potentially uncontrollable effects due to a potential 
switch in macrophage polarization or due to induction of macrophage cholesterol efflux by apoA-I-containing 
particles in the  medium54. Moreover, since the commercially available serum preparations are derived from vari-
ous animal species, from individual human subjects or various human subpopulations without standardization, 
much compositional lot-to-lot variation  exists55. Finally, sera also contain variable concentrations of TGF-β, 
a strong inhibitor of macrophage  activation56. Based on the above knowledge, the present study utilized strict 
serum-free cell culture conditions consisting of “macrophage serum-free medium” with a given concentration 
of either M-CSF or GM-CSF and in the absence of any added cytokines. This allowed us to avoid an uncontrol-
lable heterogeneity of CSF-polarized subpopulations of human macrophages, and to identify CSF-sensitive 
genes. Importantly, the polarized macrophages exhibited memory for CSF-specific antigen expression patterns 
 (CD68+/CD14+ and  CD68+/CD14−) previously verified under more complex cell culture  conditions17,19, which 
resembled those existing in human atherosclerotic  plaques19. Moreover, the present data extend earlier observa-
tions by demonstrating that an increased foam cell-forming potential of M-CSF-polarized macrophages exposed 
to native or modified  LDL19,34 does not require any additional serum-derived components.
Consistent with earlier observations by Kruth and  coworkers19, we found that the presence of either CSF 
during the monocyte-to-macrophage differentiation period distinctly affected the gene profiles, when studied in 
fully mature macrophages. Interestingly, our findings regarding the expression of lipid metabolic genes concur 
with that  study19 for CCL2 and ABCG1, whilst other data such as increased levels of PPARγ and LXR observed 
for GM-MØ did not. Overall, both the foam cell-forming capacity and pro-inflammatory potential of M-CSF-
treated macrophages was stronger than that of GM-CSF-treated macrophages. However, cholesterol loading 
modified the M-CSF-dependent polarization of a set of genes regulating macrophage inflammatory responses 
and also resulted in foam cells with a milder pro-inflammatory state. Of interest, in vivo, increased cholesterol 
efflux from tissues to plasma HDL has been reported in M-CSF-treated hypercholesterolemic WHHL  rabbits34. 
In line with this observation, we found that despite the more abundant scavenger receptor-mediated uptake 
of acetylated-LDL particles by M-CSF-polarized foam cells, these cells were highly efficient in counteracting 
intracellular free cholesterol accumulation by enhancing the ACAT1-mediated cholesterol  esterification57 and 
by increasing the rate of ABC transporter-mediated cholesterol efflux. Therefore, the abundant uptake of LDL by 
M-MØ with simultaneous yet unaffected cholesterol efflux was responsible for the high lipid load of these cells 
at any stage. These distinct responses of CSF-polarized macrophage foam cells revealed that cholesterol load-
ing may alter the expression of specific M-CSF polarization-induced genes towards a less atheroinflammatory 
phenotype, thereby revealing that these foam cells had gained atheroprotective features.
Attenuation of the CSF-dependent phenotypic divergence of macrophages based on cholesterol loading was 
exemplified by the convergence in the expression of ABCG1, a cholesterol efflux transporter also possessing 
anti-inflammatory effects demonstrated in vitro and in mice in vivo13,31,58–60, and in the expression of CCL2 
as an early component of the pro-inflammatory response in  atherosclerosis32,61. In fact, the M-CSF/GM-CSF-
ratios of ABCG1 and CCL2 mRNA expression in the non-loaded macrophages tended to approach value 1 
(i.e. unchanged) in the foam cells (Supplementary Fig. S5). To our knowledge, the present study exploiting a 
well-defined serum-free cell culture system provides the first evidence that cholesterol loading can override the 
differential inflammatory profiles in CSF-polarized macrophages by reprogramming the gene expression levels 
of both ABCG1 and CCL2 towards an anti-inflammatory phenotype.
Although macrophage cholesterol accumulation is intuitively linked to accelerated atherogenesis, we have 
observed that the conversion of cultured human macrophages into foam cells suppresses their proinflammatory 
responses to M1-polarizing  factors62. Moreover, it has been shown in vivo that the foam cells in apoE knock-out 
mice express a beneficial pro-fibrotic phenotype, which tends to restore the stability of atherosclerotic  plaques63. 
This suggests that the foamy transformation of some macrophage subtypes may represent beneficial features 
in maintaining vascular homeostasis, at least in macrophage-rich early lesions. To test this notion further, we 
activated macrophages with LPS, which has been widely used as a potent stimulatory agent for transcription of 
several genes encoding proinflammatory mediators in macrophages and thereby inducing an inflammatory state. 
In vivo studies in mice have shown that while M-CSF primes macrophages for LPS-dependent cytokine induc-
tion such as IL-1β, TNF-α and IFN-γ64, treatment with GM-CSF alters the LPS-induced cytokine expression and 
decreases the synthesis of proinflammatory cytokines thereby increasing their anti-inflammatory  properties65. 
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Notably, we found that cholesterol loading, by suppressing LPS-dependent upregulation of the expression of IL1B, 
TNFA, and CXCL8, reduced the pro-inflammatory gene expression profile in both macrophage subtypes. Similar 
attenuation of pro-inflammatory response in LPS-activated macrophages, as found in the present study, has been 
observed in mouse peritoneal macrophages treated with ox-LDL66. Under such conditions, the transcriptional 
machinery of LPS-induced pro-inflammatory genes was inhibited, suggesting that ox-LDL loading targets spe-
cific TLR-induced mechanisms required for the upregulated expression of a subset of pro-inflammatory  genes66. 
In line with these findings, other reports have indicated that macrophages cholesterol accumulation does not 
lead to an inevitable pro-inflammatory phenotype, but associate with suppression of pro-inflammatory gene 
expression  instead24,62,67. Importantly, a mechanistic link between cholesterol accumulation and suppression 
of inflammation in macrophages has been suggested due to a regulated accumulation of desmosterol in cells as 
the last intermediate in the pathway of cholesterol  biosynthesis68. On the whole, the above findings demonstrate 
that macrophage foam cells initiate a transcriptional program that prevents inflammatory responses during 
cholesterol loading, as also shown in vitro in the present study.
LXR-dependent signaling modulates the subcellular responses elicited by macrophage cholesterol  efflux35, 
which is partly controlled at the transcriptional level by nuclear receptors in response to sterol loading-induced 
ABCA1 transporter and stimulation of lipid efflux to extracellular  acceptors69. In human macrophage foam cells, 
both ABCA1 and ABCG1 are induced via oxysterol-dependent LXR activation, but also differentially regulated 
by PPAR-agonists. Indeed, ABCA1 is regulated by both PPARα and PPARγ, while ABCG1 is regulated by PPARγ 
 alone35. Moreover, the concerted expression of ABCA1 and ABCG1 in THP-1 macrophages likely relies on a 
PPARγ-LXR-dependent  pathway70. Of interest to the present study, M-CSF has been shown to rapidly repress 
(within 6 h) the expression of ABCG1 in human  macrophages71. Notably, we found that the sharp increase of 
ABCG1 expression in response to ac-LDL, ox-LDL, or native LDL in the M-MØ subtype was paralleled by over-
expression of LXRA and PPARA , but not that of PPARG . These M-MØ responses contrasted those of the GM-MØ 
subtype, in which ABCG1 was only slightly increased while PPARG was exclusively upregulated. Studies in 
THP-1 cells treated with LXR-agonists have shown that ABCG1 is very sensitive to LXR-dependent  induction72, 
a finding compatible with our results on the M-MØ subtype. Indeed, our data do not support an involvement 
of PPARγ in ABCG1 induction, but rather suggest a specific LXRα gain-of-function activity during cholesterol 
loading in M-CSF-polarized macrophages. Importantly, LXRs are thought to reciprocally regulate genes linked 
to lipid efflux and  inflammation73. Therefore, while mouse macrophages induce ABCA1 expression in response 
to LXR ligands, genes related to inflammation, such as CCL2, are being repressed. Previously, a reduced down-
stream expression of CCL2 has been linked to LXR  activation74. Conversely, more recent studies have found 
that cholesterol efflux can remodel the lipidome of foam  cells75. A regulated increase of desmosterol underlies 
the activation of LXR target genes and thereby discloses a mechanistic link between cholesterol accumulation 
and suppression of macrophage  inflammation68. On the contrary, in the brain of Abcg1/Abcg4-deficient mice, 
several sterol intermediates of the cholesterol biosynthetic pathway, desmosterol among them, were increased by 
two- to threefold and associated with increased expression of LXR target genes, including ABCA1, and increased 
secretion of  apoE76. Altogether, the present data show that expression of both ABCG1 and CCL2 appears to be 
regulated in an opposite pattern by LXRα in M-CSF-polarized foam cells. Furthermore, our results demonstrate 
that, provided foam cells are formed, the degree of ABC transporter mRNA upregulation is associated with total 
cholesterol load in the macrophages and independent of the type of LDL used for cholesterol loading as well as 
the CSF subtype of macrophages.
Earlier, mouse macrophages were found to be more competent accessory cells in supporting T cell prolifera-
tion when differentiated with GM-CSF rather than with M-CSF37. Complementary to those observations, we 
observed that the GM-MØ were acting as more potent accessory cells compared to the M-MØ. Moreover, in 
agreement with Munn et al.77, the macrophages differentiated under the influence of M-CSF did acquire the 
ability to suppress T cell proliferation. Since this accessory effect was specific to the foam cells of the GM-MØ 
subtype, the overall findings suggest that the intrinsically divergent properties elicited by either CSF in mac-
rophages for regulating T cell proliferation were not affected by the cholesterol loading.
A potential limitation of the present work is that it focused on the mRNA expression of selected genes, which 
does not always reflect the standard dichotomy of the translational process into a functional protein. Neverthe-
less, our study demonstrates distinct metabolic responses to cellular cholesterol loading and cholesterol efflux 
in M-CSF- and GM-CSF-differentiated human macrophages in vitro. Importantly, the effects of cholesterol 
loading on the studied genes were segregated into those remaining as quiescent markers of the CSF-polarized 
cells, e.g. the CD antigens, and those altering their expression in the foam cells, notably ABCG1 and CCL2. Thus, 
while the CSFs trigger monocyte transition into macrophages and also condition the alternatively generated 
macrophages to potentially distinct atheroinflammatory cytokine-mediated responses, the subsequent process 
of foam cell formation, i.e., in the absence of any accessory pro-inflammatory stimuli, evidently attenuated 
their ultimate pro-inflammatory potential. This information is of crucial importance as the primary actions of 
macrophages in atherosclerotic lesions relate to the regulation of two interrelated processes, namely cholesteryl 
ester storage and inflammation. Collectively, our results suggest that irrespective of the type of CSF-polarization, 
the transformation of lesional macrophages into foam cells not only protects the cells from the toxicity of free 
cholesterol but also reduces their pro-inflammatory actions in the atherosclerotic lesions. Despite our efforts, 
however, the present cell culture method remains an incomplete surrogate of a model in the complex and ever-
changing extracellular microenvironment in which the lesional macrophages reside during atherogenesis. But 
even so, our system offers a delicate framework for future studies, in which the effects of M-CSF and GM-CSF 
on macrophage polarization and biology, in general, can be studied in a more complex and well-defined culture 
media using time-varying variables, i.e. covering the various stages along the long path from a monocyte to a 
macrophage foam cell, and beyond.
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Methods
Human plasma lipoproteins. Plasma derived from healthy volunteers was supplied by the Finnish Red 
Cross Blood Service (Helsinki, Finland). Human LDL (1.019–1.050 g/mL) and  HDL2 (1.063–1.125 g/mL) were 
isolated by sequential ultracentrifugation using KBr for density adjustments, according to standard  techniques78. 
To prevent lipoprotein oxidation, all steps were performed in the presence of 3 mM EDTA. Lipoprotein con-
centrations are expressed for their protein  content79. LDL was acetylated (acetyl-LDL) with acetic anhydride, 
as  described80. To generate oxidized LDL (ox-LDL), native LDL (1 mg protein/mL) was incubated with 10 µM 
 CuSO4 at 37 °C for 18 h, following the method originally described by Steinbrecher and co-workers81. At the end 
of the incubation, the oxidation reactions were terminated by adding EDTA (final concentration of 100 µM) to 
the incubation mixture, and by cooling the sample on ice. The various modified LDL preparations were derived 
from a single LDL preparation (Supplementary Table S1). The preparations were endotoxin-free when assayed 
by the Limulus Amebocyte Lysate kit according to the manufacturer’s instructions (Cambrex Bio Science Walk-
ersville Inc. MD, USA). All lipoprotein preparations were stored in dark at 4 °C until use.
Primary monocyte‑macrophage cultures. The experimental outline is shown in Supplementary 
Fig. S1. Human monocytes were differentiated into macrophages in the presence of  CSF62, with modifications 
relevant to this particular study. Buffy coats from volunteer healthy donors were provided by the Finnish Red 
Cross Blood Transfusion Service, Helsinki, Finland (supplied under permits 45/2012 and 2/2014), and they were 
layered over Ficoll-Paque and centrifuged at 800×g for 30 min. As previously  described62, the peripheral blood 
mononuclear cells (PBMC) were collected, sedimented, and washed 3 times with PBS to remove contaminat-
ing platelets, and finally suspended in Dulbecco’s Modified Eagle Medium (DMEM, Lonza, Verviers, Belgium). 
The washed PBMCs were transferred onto 24-well plates (1.5 million cells/well) and allowed to adhere for 1 h, 
after which the medium was removed and replaced by adding macrophage serum-free medium (SFM, Invitro-
gen, Carlsbad, CA) containing 50 ng/mL of M-CSF or 10 ng/mL of GM-CSF (both from Biosite Ltd, UK). The 
cells were then cultured for 6 days in SFM, and, during this period the CSF-containing medium was replaced 
every 2–3 days in an attempt to keep the concentrations of the CSFs as constant as possible. After 6 days of cul-
ture, the cells were ready for experimentation as judged by their phenotypical (morphological) conversion into 
 macrophages82. Macrophage maturation was also confirmed by immunostaining of the cells for the common 
macrophage marker CD68. Altogether, we investigated macrophages derived from a total of 75 human donors.
Immunostaining of cultured monocyte‑derived macrophages. Detection of the common mac-
rophage markers CD14 and CD68 was performed as described  earlier19. In brief, cells were first rinsed 3 times 
with phosphate-buffered saline (PBS, Lonza, Verviers, Belgium) and then fixed in culture dishes with methanol 
(VWR International, West Chester, PA) at − 20  °C for 5 min, and finally blocked with PBS containing 10% 
normal human serum (Pel-Freez, Milwaukee, WI) for 20 min. The cells were then incubated for 60 min in the 
presence of 2 µg/mL of primary antibody, which was goat anti-human CD68 or mouse anti-human CD14 (both 
from Santa Cruz Biotechnology, Santa Cruz, CA) or mouse anti-human mature macrophage, clone 25F9 (from 
BMA Biomedicals, Augst, Switzerland). Non-specific goat and mouse IgGs (Santa Cruz Biotechnology) were 
used as negative controls. After washes, 5 µg/mL of a biotinylated secondary antibody, which was either horse 
anti-goat or goat anti-mouse IgG (both from Vector Laboratories, Burlingame, CA) was added and incubated 
for 45 min, and then followed by 15 min incubation with 10 µg/mL of avidin-labeled Alexa 488 or Alexa 594 
(Molecular Probes, Eugene, OR). The cells were rinsed 3 times in PBS after each incubation at room temperature.
Flow cytometry. Analysis of cell surface antigens was performed as  described83, with slight modifications. 
Briefly, the cells were detached from culture dishes with Accutase solution (Chemicon) and resuspended in pre-
chilled fluorescence-activated cell sorter buffer (PBS with 0.5% BSA and 0.025%  NaN3), and fixed with 2% para-
formaldehyde/PBS. After 2 washes at room temperature, the cells were blocked with 5% FBS/PBS, permeabilized 
with saponin, and stained for CD68, CD11c and CCR7 by using fluorescent-labeled antibodies for 30 min on ice. 
Finally, following 2 washes at room temperature, the cells were analyzed by using an LSR II flow cytometer (BD 
Biosciences, San Jose, CA). Isotype-matched mouse IgGs were used as negative controls.
Generation of macrophage foam cells and measurement of their cellular cholesterol con‑
tents. Monocyte-derived macrophages of each CSF subtype were incubated in DMEM containing 25 µg/mL 
of acetyl-LDL for 24 h to generate macrophage foam cells, as described  previously82. For the measurement of 
cellular cholesterol contents, the cells were detached from the culture dishes, sonicated, and the protein levels in 
the cellular lysates were then measured. Cellular lipids were extracted with hexane–isopropanol (3:2; v/v). Free 
cholesterol and cholesteryl esters in the lipid extracts were separated by high-performance thin-layer chroma-
tography (HP-TLC) followed by quantitative analysis with an automatic plate scanner (CAMAG TLC). Total 
cholesterol content was calculated as the sum of free and esterified cholesterol fraction in each sample. In other 
experiments, the respective CSF was added to the cholesterol loading medium at the same concentration as 
used for monocyte differentiation, or the macrophages were loaded with cholesterol by incubation for 24 h with 
oxidized-LDL or native LDL (25 µg/mL, each).
Cholesterol efflux. Macrophage foam cells of either CSF subtype were washed with PBS, after which 
fresh DMEM was added. The DMEM contained either purified human lipid-free apoA-I (10  µg/mL; kindly 
provided by Dr. Peter Lerch of the Swiss Red Cross),  HDL2 (25 µg/mL), or human plasma (2.5%, vol/vol) and 
cholesterol efflux was evaluated, as previously  described83. In brief, after incubation for 18 h with the various 
13
Vol.:(0123456789)
Scientific Reports |         (2021) 11:4923  | https://doi.org/10.1038/s41598-021-84249-y
www.nature.com/scientificreports/
cholesterol acceptors, the media were collected, centrifuged at 300g for 10 min to remove cellular debris, after 
which the  [3H]-radioactivity in the medium and in the washed cells was determined by scintillation count-
ing. The fractional cholesterol efflux (in %) was calculated as follows: dpm in medium/(dpm in cells + dpm in 
medium) ×  10083. Cholesterol efflux into the incubation medium in the absence of any added extracellular accep-
tor was subtracted from the efflux values obtained in the presence of acceptors. The concentration of apoE in 
cell-free media was determined by ELISA, as described  previously84.
Analysis of gene expression. The mRNA expression levels of selected genes encoding proteins related 
to cholesterol balance and inflammation were analyzed by quantitative RT-PCR in non-loaded macrophages 
and cholesterol-loaded macrophage foam cells of each CSF subtype. In some experiments, gene expression was 
analyzed in activated macrophages after their incubation for 3 h with LPS (100 ng/mL). Real-time PCR was per-
formed as previously  described85. Accordingly, total cellular RNA was isolated using the RNeasy Plus Kit with 
the removal of genomic DNA according to the manufacturer’s instructions (Qiagen, Valencia, CA). Nucleic acid 
concentrations were determined by NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilm-
ington, DE). The RNA from each sample was then converted to cDNA using Moloney-Murine Leukaemia Virus 
(M-MLV) reverse transcriptase and random hexamers (both from Promega, Wilmington, WI, USA) for 55 min 
at 48 °C. For PCR, the samples were amplified in duplicate with ABI Prism 7500 Sequence Detector System using 
TaqMan Universal or Power SYBR Green PCR Master Mix (all from PE Applied Biosystems) with the program 
settings: 10 min pre-incubation at 95 °C followed by 40 amplification cycles consisting of 15-s denaturation at 
94 °C and primer annealing and polymerase extension for 60 s at 60 °C. Oligonucleotide sequences of the quan-
titative PCR primers and 5′-FAM labeled hydrolysis probes with non-fluorescent quencher are shown in Sup-
plementary Table S2. The data were normalized relative to an endogenous control glyceraldehyde-3 phosphate 
dehydrogenase (GAPDH) by applying the delta-deltaCt algorithm.
Evaluation of T cell proliferation. T cells were purified from buffy coats using RosetteSep human T cell 
enrichment cocktail according to the manufacturer’s instructions (StemCell Technologies, Vancouver, Canada). 
To remove adhered monocytes, the obtained T cells were purified further by incubating them for 1 h at 37 °C 
in serum-free DMEM. The purified T cells were cultured in serum-free OpTmizer medium (Invitrogen) or 
cryopreserved until used. M-MØ and GM-MØ derived from the same buffy coats were incubated in the absence 
or presence of acetyl-LDL (25 µg/mL) for 24 h in serum-free DMEM. The cells were extensively washed and 
the previously cryopreserved autologous T cells (125,000 to 500,000 cells/mL; T cell: macrophage ratio ranging 
from 0.5:1 to 1.5:1) were added and co-cultured in serum-free OpTmizer in the presence or absence of 10 µg/
mL phytohemagglutinin (PHA: Sigma). After 4 days, the plates were swirled, pipetted vigorously to disrupt any 
clump, and the T cell numbers in the medium were counted using a nucleocounter (NC-200 Cell Counter Che-
moMetec A/S). As a control, macrophages and T cells were cultured alone. Under our experimental conditions, 
only negligible (less than 5000 cells) numbers of macrophages were found in the medium. The T cell prolifera-
tion is expressed as a stimulation index (SI), which was calculated by dividing the numbers of viable cells in the 
medium in the presence of macrophages by the number of viable cells in the medium containing T cells only.
Statistics. Differences in continuous variables from 2 experimental groups were assessed by using Wilcoxon 
Signed-Rank test or unpaired-samples t-test, when appropriate. Statistical significance was set at p < 0.05. One-
way ANOVA with Bonferroni’s Multiple Comparison Test was used to compare data from 3 or more groups. 
GraphPad Prism 5.0 software (GraphPad, San Diego, CA) was used for all statistical analyses.
Data availability
All data generated or analyzed during this study are included in this article and its Supplementary Information. 
No datasets were generated or analyzed during the present study.
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